Figure 6
From: Detection and characterization of mineralo-organic nanoparticles in human kidneys
Immunogold staining of mineralo-organic NPs and kidney granules.
(A) HS-NPs prepared as in Fig. 4 and (B) human kidney tissues were processed for thin-section TEM and immunogold labeling. The antibodies used are indicated at the bottom right corner of each panel. Treatment without primary antibody was used as a negative control (panels A4 and B4).
